Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 What are the Therapeutic Advances in Neurology? Opinions from World Experts.

Literature DB >> 21180562

What are the Therapeutic Advances in Neurology? Opinions from World Experts.

Gordon Mallarkey¹.

Abstract

Year: 2008 PMID： 21180562 PMCID： PMC3002537 DOI： 10.1177/1756285608094210

Source DB: PubMed Journal: Ther Adv Neurol Disord ISSN： 1756-2856 Impact factor: 6.570

× No keyword cloud information.

10 in total

Review 1. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes.

Authors: Tracy Glauser; Elinor Ben-Menachem; Blaise Bourgeois; Avital Cnaan; David Chadwick; Carlos Guerreiro; Reetta Kalviainen; Richard Mattson; Emilio Perucca; Torbjorn Tomson
Journal: Epilepsia Date: 2006-07 Impact factor: 5.864

2. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group.

Authors: D M Treiman; P D Meyers; N Y Walton; J F Collins; C Colling; A J Rowan; A Handforth; E Faught; V P Calabrese; B M Uthman; R E Ramsay; M B Mamdani
Journal: N Engl J Med Date: 1998-09-17 Impact factor: 91.245

3. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus.

Authors: B K Alldredge; A M Gelb; S M Isaacs; M D Corry; F Allen; S Ulrich; M D Gottwald; N O'Neil; J M Neuhaus; M R Segal; D H Lowenstein
Journal: N Engl J Med Date: 2001-08-30 Impact factor: 91.245

Review 4. Anticonvulsant therapy for status epilepticus.

Authors: K Prasad; K Al-Roomi; P R Krishnan; R Sequeira
Journal: Cochrane Database Syst Rev Date: 2005-10-19

Review 5. Emerging therapies for migraine.

Authors: Peter J Goadsby
Journal: Nat Clin Pract Neurol Date: 2007-11

6. Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy.

Authors: M J Brodie; E Perucca; P Ryvlin; E Ben-Menachem; H-J Meencke
Journal: Neurology Date: 2007-02-06 Impact factor: 9.910

7. Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial.

Authors: Richard A C Hughes; Peter Donofrio; Vera Bril; Marinos C Dalakas; Chunqin Deng; Kim Hanna; Hans-Peter Hartung; Norman Latov; Ingemar S J Merkies; Pieter A van Doorn
Journal: Lancet Neurol Date: 2008-02 Impact factor: 44.182

8. Calcitonin gene-related peptide (CGRP) antagonists and migraine: is this a new era?

Authors: Peter J Goadsby
Journal: Neurology Date: 2008-04-15 Impact factor: 9.910

9. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial.

Authors: Anthony G Marson; Asya M Al-Kharusi; Muna Alwaidh; Richard Appleton; Gus A Baker; David W Chadwick; Celia Cramp; Oliver C Cockerell; Paul N Cooper; Julie Doughty; Barbara Eaton; Carrol Gamble; Peter J Goulding; Stephen J L Howell; Adrian Hughes; Margaret Jackson; Ann Jacoby; Mark Kellett; Geoffrey R Lawson; John Paul Leach; Paola Nicolaides; Richard Roberts; Phil Shackley; Jing Shen; David F Smith; Philip E M Smith; Catrin Tudur Smith; Alessandra Vanoli; Paula R Williamson
Journal: Lancet Date: 2007-03-24 Impact factor: 79.321

10. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial.

10 in total

1 in total

1. The future of neurology.

Authors: José Biller; Michael J Schneck
Journal: Front Neurol Date: 2011-02-04 Impact factor: 4.003

1 in total